.png){kind=icon}
.png){kind=icon}
Return
Non-HLA antibodies worsen the histological phenotype and prognosis of antibody mediated rejection in kidney allografts
.png){kind=icon}
OA
AI
E
O
L
V
L
M
B
J
C
M
M
D
K
T
P
A
J
C
Q
C
DOI：10.1016/j.kint.2026.06.031.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Antibody-mediated rejection (AMR) remains a leading cause of kidney allograft failure, with both HLA and non-HLA antibodies implicated in its pathogenesis. The contribution of non-HLA antibodies (non-HLA Abs) to microvascular inflammation (MVI) and graft outcome, particularly in cases lacking donor-specific anti-HLA antibodies (HLA-DSAs), remains incompletely understood.
Keywords:
Antibody-mediated rejection
non-HLA antibodies
kidney rejection
endothelial inflammation
Journal
IF:
12.6
Papers:
1.6W
Citations:
4.8W
Organization
No organization information available
Cited Papers